Metizolam
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Dependence liability |
Moderate |
| Routes of administration |
Oral, sublingual, rectal |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C16H13ClN4S |
| Molar mass | 328.82 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Metizolam (also known as desmethyletizolam) is a thienotriazolodiazepine that is the demethylated analogue of the closely related etizolam.
Legal status
Following its sale as a designer drug, metizolam was classified as controlled substance in Sweden on 26. January 2016.
See also
| 5-HT1AR agonists | |
|---|---|
| GABAAR PAMs |
|
|
Gabapentinoids |
|
| Antidepressants |
|
|
Sympatholytics |
|
| Others | |
| |
| PAFR |
|
||||
|---|---|---|---|---|---|
| Others |
|
||||
| |||||